Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: A report from the German Hodgkin's Lymphoma Study Group

Journal of Clinical Oncology

Volumn 23, Issue 30, 2005, Pages 7555-7564

  Behringer, Karolin ^a   Breuer, Kai ^a   Reineke, Thorsten ^a   May, Michael ^a   Nogova, Lucia ^a   Klimm, Beate ^a   Schmitz, Tatiana ^a   Wildt, Ludwig ^a   Diehl, Volker ^a   Engert, Andreas ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; ORAL CONTRACEPTIVE AGENT; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ABVD PROTOCOL; ANTINEOPLASTIC AGENT; BEACOPP PROTOCOL; COPP PROTOCOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE ESCALATION; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTIPLE CYCLE TREATMENT; ORAL CONTRACEPTION; PRIORITY JOURNAL; PROGNOSIS; SECONDARY AMENORRHEA; AGE; AMENORRHEA; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RISK FACTOR; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AMENORRHEA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; CONTRACEPTIVES, ORAL; CYCLOPHOSPHAMIDE; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; ETOPOSIDE; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MENSTRUAL CYCLE; MIDDLE AGED; NEOPLASM STAGING; PREDNISONE; PROCARBAZINE; RISK FACTORS; TREATMENT OUTCOME; VINBLASTINE; VINCRISTINE;

EID: 32944474118     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.08.138     Document Type: Article

References (46)

1. Rosenberg S: The management of Hodgkin's disease: Half a century of change- The Kaplan Memorial Lecture. Ann Oncol 7:555-560, 1996
2. Greco RS, Acheson RM, Foote FM: Hodgkin disease in Connecticut from 1935 to 1962: The bimodal incidence curve in the general population and survival in untreated patients. Arch Intern Med 134:1039-1042, 1974
3. Kapusta L, Groot-Loonen J, Thijssen JM, et al: Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy. Med Pediatr Oncol 41:426-435, 2003
4. Hull MC, Morris CG, Repine CJ, et al: Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290:2831-2837, 2003
5. Hirsch A, Vander Els N, Straus DJ, et al: Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease. J Clin Oncol 14:1297-1305, 1996
6. Horning SJ, Adhikari A, Rizk N, et al: Effect of treatment for Hodgkin's disease on pulmonary function: Results of a prospective study. J Clin Oncol 12:297-305, 1994
7. Josting A, Wiedenmann S, Franklin J, et al: Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: A report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3440-3446, 2003
8. Rueffer U, Josting A, Franklin J, et al: Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis. J Clin Oncol 19:2026-2032, 2001
9. Swerdlow AJ, Barber JA, Hudson GV, et al: Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 18:498-509, 2000
10. van Leeuwen FE, Klokman WJ, Veer MB, et al: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18:487-497, 2000
11. Travis LB, Gospodarowicz M, Curtis RE, et al: Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 94:182-192, 2002
12. van Leeuwen FE, Klokman WJ, Stovall M, et al: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95:971-980, 2003
13. Bhatia S, Yasui Y, Robison LL, et al: High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group. J Clin Oncol 21:4386-4394, 2003
14. Kreuser E, Felsenberg D, Behles C, et al: Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ ABVD chemotherapy for Hodgkin's disease. Ann Oncol 3:105-110, 1992 (suppl 4)
15. Rueffer U, Breuer K, Josting A, et al: Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol 12:1307-1311, 2001
16. Fitoussi Eghbali H, Tchen N, et al: Semen analysis and cryoconservation before treatment in Hodgkin's disease. Ann Oncol 11:679-684, 2000
17. Sieber MFJ, Franklin J, Tesch H, et al: Two cycles ABVD plus extended field radiotherapy is superior to radiotherapy alone in early stage Hodgkin's disease: Results of the German Hodgkin's Lymphoma Study Group (GHSG) Trial HD7. Blood 100:A341, 2002 (abstr)
18. Engert A, Schiller P, Josting A, et al: Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3601-3608, 2003
19. Dienl V, Franklin J, Pfreundschuh M, et al: Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 348: 2386-2395, 2003
20. Franchi-Rezgui P, Rousselot P, Espie M, et al: Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas. Hematol J 4:116-120, 2003
21. Horning SJ, Hoppe RT, Kaplan HS, et al: Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 304:1377-1382, 1981
22. Byrne J: Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol 33:24-28, 1999
23. Howell SJ, Shalet SM: Fertility preservation and management of gonadal failure associated with lymphoma therapy. Curr Oncol Rep 4:443-452, 2002
24. Goldhirsch A, Gelber RD, Castiglione M: The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients: The International Breast Cancer Study Group. Ann Oncol 1:183-188, 1990
25. Whitehead E, Shalet SM, Blackledge G, et al: The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 52:988-993, 1983
26. Schilsky R, Sherins R, Hubbard S, et al: Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med 71:552-556, 1981
27. Familian G, Caggiati A, Nottola S, et al: Infrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod 8:2080-2087, 1993
28. Byrne J, Fears TR, Gail MH, et al: Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166:788-793, 1992
29. Larsen EC, Muller J, Schmiegelow K, et al: Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88:5307-5314, 2003
30. Howell S, Shalet S: Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 27:927-943, 1998
31. van den Berg H, Furstner F, van den Bos C, et al: Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. Pediatr Blood Cancer 42:210-215, 2004
32. Bines J, Oleske DM, Cobleigh MA: Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14:1718-1729, 1996
33. Gaffan J, Holden L, Newlands ES, et al: Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours: A retrospective long-term follow-up study. Br J Cancer 89:1849-1854, 2003
34. Mackie Ej, Radford M, Shalet SM: Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 27: 74-78, 1996
35. Bonadonna G: Modern treatment of malignant lymphomas: A multidisciplinary approach? The Kaplan Memorial Lecture. Ann Oncol 5:5-16, 1994 (suppl 2)
36. Andre M, Brice P, Cazals D, et al: Results of three courses of Adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II and IIIA). Hematol Cell Ther 39:59-65, 1997
37. Brusamolino E, Lunghi F, Orlandi E, et al: Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radiotherapy: Analysis of efficacy and long-term toxicity. Haematologica 85:1032-1039, 2000
38. Blumenfeld Z, Dann E, Avivi I, et al: Fertility after treatment for Hodgkin's disease. Ann Oncol 13:138-147, 2002 (suppl 1)
39. Chapman R, Sutcliffe S: Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood 58:849-851, 1981
40. Blatt J: Pregnancy outcome in long-term survivors of childhood cancer. Med Pediatr Oncol 33:29-33, 1999
41. Byrne J, Rasmussen SA, Steinhorn SC, et al: Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 62:45-52, 1998
42. Poirot C, Vacher-Lavenu MC, Helardot P, et al: Human ovarian tissue cryopreservation: Indications and feasibility. Hum Reprod 17:1447-1452, 2002
43. Kim SS, Radford J, Harris M, et al: Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod 16:2056-2060, 2001
44. Oktay K, Buyuk E, Veeck L, et al: Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363:837-840, 2004
45. Donnez J, Dolmans MM, Demylle D, et al: Livebirth after orthotopic transplantation of cryo-preserved ovarian tissue. Lancet 364:1405-1410, 2004
46. Shaw JM, Bowles J, Koopman P, et al: Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod 11:1668-1673, 1996